Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...
The FDA banned the use of red dye No. 3 in foods and medicines sold in the U.S. because it has been shown to cause cancer in ...
The US Food and Drug Administration has banned the use of red dye No. 3 in food and ingested drugs, more than 30<a ...
The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, ...
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® ...
This practice is not approved by the U.S. Food and Drug Administration (FDA). Is Eating Once A Day A Good Idea? Experts Share ...
This may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...